Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Prostatic Neoplasms 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Leukemia 2Waldenstrom Macroglobulinemia 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma 1Rectal Neoplasms 1Precancerous Conditions 1Polycystic Ovary Syndrome 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Leukemia, Prolymphocytic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1Hemangioma, Cavernous, Central Nervous System 1Heart Failure 1

Interventions

Sildenafil Citrate 4Alprostadil 2alpha-Tocopherol 1Vitamin E 1Tacrolimus 1Surveys and Questionnaires 1Pentoxifylline 1Erythropoietin 1Atorvastatin 1Arginine 1ArginMax 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Erectile Dysfunction × Atorvastatin × Clear all
NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
14 enrolled 9 charts

Erectile Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡